170 related articles for article (PubMed ID: 22389885)
1. A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.
Ahn JY; Seo YH; Park PW; Kim KH; Park MJ; Jeong JH; Park SH; Song YH
Ann Lab Med; 2012 Mar; 32(2):162-6. PubMed ID: 22389885
[TBL] [Abstract][Full Text] [Related]
2. Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.
Bischin AM; Dorer R; Aboulafia DM
Clin Med Insights Blood Disord; 2017; 10():1179545X17692544. PubMed ID: 28579851
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment with dose-adjusted EPOCH-R for triple-hit lymphoma having BCL2, BCL6 and MYC translocations].
Hashimoto A; Fujimi A; Kanisawa Y; Nakajima C; Hayasaka N; Yamada S; Okuda T; Minami S; Matsumoto T; Shibata T; Hamaguchi K; Kamihara Y; Iwasaki S; Kato J
Rinsho Ketsueki; 2015 Jul; 56(7):905-10. PubMed ID: 26256929
[TBL] [Abstract][Full Text] [Related]
4. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
[TBL] [Abstract][Full Text] [Related]
5. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
6. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Stejskalová E; Kabícková E
Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
[TBL] [Abstract][Full Text] [Related]
7. Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.
Maruyama D; Watanabe T; Maeshima AM; Nomoto J; Taniguchi H; Azuma T; Mori M; Munakata W; Kim SW; Kobayashi Y; Matsuno Y; Tobinai K
Int J Hematol; 2010 Dec; 92(5):732-43. PubMed ID: 21120644
[TBL] [Abstract][Full Text] [Related]
8. [Pathological diagnosis of pediatric Burkitt lymphoma involving bone marrow].
Sun Q; Chen Z; Liu E; Li Z; Yang Q; Sun F; Ma Y; Zhang H; Zhang P; Ru K
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):95-9. PubMed ID: 25916639
[TBL] [Abstract][Full Text] [Related]
9. Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients.
Lu B; Zhou C; Yang W; Huang H; Gao Z; He Y; Liu H; Zhou X; Gong L
Leuk Lymphoma; 2011 Dec; 52(12):2356-64. PubMed ID: 21740296
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic challenges in a case of B cell lymphoma unclassifiable with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
So CC; Yung KH; Chu ML; Wan TS
Int J Hematol; 2013 Oct; 98(4):478-82. PubMed ID: 23959583
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological prognostic factors of 24 patients with B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Miyamoto K; Kobayashi Y; Maeshima AM; Taniguchi H; Nomoto J; Kitahara H; Fukuhara S; Munakata W; Maruyama D; Tobinai K
Int J Hematol; 2016 Jun; 103(6):693-702. PubMed ID: 27095041
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
13. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
[TBL] [Abstract][Full Text] [Related]
14. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.
Pillai RK; Sathanoori M; Van Oss SB; Swerdlow SH
Am J Surg Pathol; 2013 Mar; 37(3):323-32. PubMed ID: 23348205
[TBL] [Abstract][Full Text] [Related]
15. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.
Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N
Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens.
Kim H; Kim HJ; Kim SH
Ann Lab Med; 2020 Sep; 40(5):361-369. PubMed ID: 32311849
[TBL] [Abstract][Full Text] [Related]
17. A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma.
Kurita N; Nishikii H; Nakamoto R; Nakamura N; Kondo Y; Okoshi Y; Suzukawa K; Hasegawa Y; Yokoyama Y; Noguchi M; Chiba S
J Clin Exp Hematop; 2011; 51(1):37-42. PubMed ID: 21628859
[TBL] [Abstract][Full Text] [Related]
18. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
[TBL] [Abstract][Full Text] [Related]
19. Triple-hit B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma associated with a novel complex karyotype including t(2;3)(q21;q27), t(8;14)(q24;q32) and t(14;18)(q32;q21).
Nakayama S; Yokote T; Iwaki K; Takayama A; Tsuji M; Hanafusa T
Br J Haematol; 2013 Mar; 160(5):569. PubMed ID: 23205706
[No Abstract] [Full Text] [Related]
20. Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.
Zhang S; Wilson D; Czader M
Ann Lab Med; 2015 Mar; 35(2):254-6. PubMed ID: 25729731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
